(Q40090279)

17 September 2017

Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells (English)

1 reference

17 September 2017

0 references

J Ruth Wu-Wong

1

1 reference

17 September 2017

Masaki Nakane

2

1 reference

17 September 2017

Junli Ma

3

1 reference

17 September 2017

Xiaoan Ruan

4

1 reference

17 September 2017

Paul E Kroeger

5

1 reference

17 September 2017

22 August 2007

1 reference

American Journal of Physiology - Renal Physiology

17 September 2017

1 reference

17 September 2017

293

1 reference

17 September 2017

5

1 reference

17 September 2017

F1592-604

1 reference

Altered nuclear receptor corepressor expression attenuates vitamin D receptor signaling in breast cancer cells

17 September 2017

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Nuclear receptors Nur77, Nurr1, and NOR-1 expressed in atherosclerotic lesion macrophages reduce lipid loading and inflammatory responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

The apolipoprotein e knockout mouse: a model documenting accelerated atherogenesis in uremia

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Vascular calcification mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

A vitamin D analog down-regulates proinflammatory chemokine production by pancreatic islets inhibiting T cell recruitment and type 1 diabetes development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Survival predictability of time-varying indicators of bone disease in maintenance hemodialysis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

1,25-Dihydroxyvitamin D(3) is a negative endocrine regulator of the renin-angiotensin system

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Integration of the NfkappaB p65 subunit into the vitamin D receptor transcriptional complex: identification of p65 domains that inhibit 1,25-dihydroxyvitamin D3-stimulated transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Vitamin D analogs: actions and role in the treatment of secondary hyperparathyroidism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

An overview of regular dialysis treatment in Japan (as of 31 December 2001).

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Mechanistic analysis of VDR-mediated renin suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Hyperphosphatemia and vascular calcification in end-stage renal disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Complications of the COX-2 inhibitors parecoxib and valdecoxib after cardiac surgery

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Hyperphosphatemia in renal failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Medial localization of mineralization-regulating proteins in association with Mönckeberg's sclerosis: evidence for smooth muscle cell-mediated vascular calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Regulation of PTH synthesis and secretion relevant to the management of secondary hyperparathyroidism in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Smooth muscle cell phenotypic transition associated with calcification: upregulation of Cbfa1 and downregulation of smooth muscle lineage markers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Survival of patients undergoing hemodialysis with paricalcitol or calcitriol therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Activated injectable vitamin D and hemodialysis survival: a historical cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Inhibition of the transcription factors AP-1 and NF-kappaB in CD4 T cells by peroxisome proliferator-activated receptor gamma ligands

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

PPARgamma and PPARdelta negatively regulate specific subsets of lipopolysaccharide and IFN-gamma target genes in macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Vitamin D analogs modulate the expression of plasminogen activator inhibitor-1, thrombospondin-1 and thrombomodulin in human aortic smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Vitamin D receptor (VDR) localization in human promyelocytic leukemia cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

VDR-mediated gene expression patterns in resting human coronary artery smooth muscle cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Role of phosphorus and vitamin D analogs in the pathogenesis of vascular calcification.

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

Elevated extracellular calcium levels induce smooth muscle cell matrix mineralization in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1152%2FAJPRENAL.00492.2006

10.1152/AJPRENAL.00492.2006

21 January 2018

Identifiers

DOI

1 reference

17 September 2017

1 reference